Chloramphenicol succinate sodium (CCRIS6204; CCRIS-6204) is an antibiotic and a prodrug of Chloramphenicol with Haemotoxicity, as Chloramphenicol succinate is a competitive substrate and inhibitor of succinate dehydrogenase (SDH).

C-215 is a novel and potent inhibitor of mycobacterial membrane protein large 3 (MmpL3).

Omadacycline tosylate (formerly PTK0796; trade name: Nuzyra), the tosylate salt of omadacycline, is a tetracycline antibiotic being developed as an oral and intravenous (IV) formulation to treat community-acquired bacterial infections such as acute bacterial skin and skin structure infections (ABSSSI), community-acquired bacterial pneumonia (CABP), and urinary tract infections (UTI). In Oct 2018, Omadacycline was approved […]

Brilacidin tetrahydrochloride (PMX-30063; PMX 30063) is a novel and potent arylamide foldamer that can mimic the amphiphilic properties of antimicrobial peptides.

Tazobactam sodium (CL-298741; YTR-830H; CL298741; YTR830H; Zerbaxa), the sodium salt of Tazobactam, is a β-lactamase inhibitor with antibacterial activity.

Pefloxacin Mesylate (also known as 1589 RB and Pefloxacinium) is a broad-spectrum and third generation of fluoroquinolone class of antibacterial agent which inhibits Topoisomerase II activity and DNA replication.

Trovafloxacin (CP-99219) is a broad-spectrum quinolone antibiotic that inhibits DNA supercoiling in various bacteria by blocking the activity of DNA gyrase and topoisomerase IV.

Solithromycin (CEM-101; OP1068; CEM101; OP-1068) is a novel and potent ketolide antibiotic with improved antimicrobial effectiveness.

Oxacillin sodium is a narrow-spectrum and potent beta-lactam antibiotic similar to flucloxacillin and is used in resistant staphylococci infections.

Lexithromycin (Erythromycin A 9-methoxime; Wy 48314) is a potent and semi-synthetic antibiotic derived from erythromycin A with antibacterial activity.